Geometry.Net - the online learning center
Home  - Nobel - Varmus Harold E
e99.com Bookstore
  
Images 
Newsgroups
Page 4     61-80 of 97    Back | 1  | 2  | 3  | 4  | 5  | Next 20
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

         Varmus Harold E:     more detail
  1. Retroviruses
  2. Biography - Varmus, Harold E(liot) (1939-): An article from: Contemporary Authors by Gale Reference Team, 2002-01-01
  3. Parity in Financing Mental Health Services: Managed Care Effects on Cost, Access and Quality by Harold E. Varmus, 1998-06
  4. Directors of the National Institutes of Health: Harold E. Varmus, Elias Zerhouni, Ruth L. Kirschstein, Rolla Dyer, Jeremy M. Berg
  5. American Ashkenazi Jews: Jason Schwartzman, Harold E. Varmus, Tim Barsky
  6. Retroviruses Slide Set by John M. Coffin, Stephen H. Hughes, et all 1998-03-15

61. Re: Who Is Harold Varmus? Article In Today's NYTIMES On "Public Library
In 1999, NIH Director harold varmus proposed a national biomedical literature servercalled EBiomed. E-Biomed reflected the visions of scholarly electronic
http://www.library.yale.edu/lso/workstation/archives/yulib-l/msg06820.html
Date Prev Date Next Thread Prev Thread Next ... Thread Index
Re: Who is Harold Varmus? article in today's NYTIMES on "Public Library of Science"
Suzanna, Ann, all, Here is another aspect of the identity of Varmus. In 1999, NIH Director Harold Varmus proposed a national biomedical literature server called "E-Biomed." E-Biomed reflected the visions of scholarly electronic publishing advocates: it would be fully searchable, free to access, and contain full text versions of both pre-print and post-publication biomedical research articles. However, in less than a year, the E-Biomed proposal was radically transformed, eliminating the pre-print section, instituting delays between article publication and posting to the archive, and changing the name to "PubMed Central." From The Real Stakes of Virtual Publishing: The Transformation of E-Biomed into PubMed Central by Rob Kling, Joanna Fortuna and Adam King. Center for Social Informatics, SLIS, Indiana University http://www.slis.indiana.edu/csi/WP/wp01-03B.html

62. NIH's Public Archive For The Refereed Literature: PUBMED CENTRAL(fwd)
message Date Mon, 30 Aug 1999 183739 -0400 From varmus, harold hvarmus@mail.nih.gov The commentary period for the E-biomed proposal has been
http://www.library.yale.edu/~llicense/ListArchives/9908/msg00057.html
Date Prev Date Next Thread Prev Thread Next ... Thread Index
NIH's Public Archive for the Refereed Literature: PUBMED CENTRAL(fwd)
http://www.nih.gov/welcome/director/pubmedcentral/pubmedcentral.htm Thank you for your help in this work. I welcome your ongoing support of PubMed Central. Harold Varmus, M.D. Director, National Institutes of Health PUBMED CENTRAL: AN NIH-OPERATED SITE FOR ELECTRONIC DISTRIBUTION OF LIFE SCIENCES RESEARCH REPORTS In the four months since we proposed E-biomed a system that would make results from the world's life sciences research community freely available on the Internet ( http://www.nih.gov/welcome/director/ebiomed/ebiomed.htm

63. Harold Varmus: New & Used Books: Find The Lowest Price
Retroviruses Compare Prices, Retroviruses By John M. Coffin, Stephen H. Hughes,harold E. varmus Paperback / Cold Spring Harbor Laboratory Press / January
http://www.fetchbook.co.uk/search_Harold_Varmus/searchBy_Author.html

About
Bookmark Recommend Us Enhance Your Site ... Help Keyword Title Author ISBN
Searched in books for Harold Varmus titles matched your search. Search took seconds. Retroviruses
By John M. Coffin Stephen H. Hughes Harold E. Varmus
Paperback / Cold Spring Harbor Laboratory Press / January 1997 / 0879695714
Books Similar to Retroviruses
Compare Prices
Book Reviews
Retroviruses
By John M. Coffin Stephen H. Hughes Harold E. Varmus
Hardcover / Cold Spring Harbor Laboratory Press / December 1997 / 0879694971
Books Similar to Retroviruses Compare Prices Book Reviews Rna Tumor Viruses: 002 By Robin Weiss Natalie Teich Harold Varmus John Coffin Paperback / Cold Spring Harbor Laboratory Pr / March 1985 / 0879691670 Books Similar to Rna Tumor Viruses: 002 Compare Prices Book Reviews By Harold E. Varmus

64. Dr. Harold Gores
Service). FY99 LABORHHS APPROPSHAROLD E. varmus (CongressionalTestimony). Gore to Visit New York, Florida, Michigan, Ohio Feb.
http://www.infoplease.com/ipsa/A0109227.html
in All Infoplease Almanacs Biographies Dictionary Encyclopedia
Infoplease Tools

65. Varmus, Tsongas Speak At Whitehead Dedication
edu * Phone 617253-2700 =varmus, Tsongas speak Director and Nobel laureate harold E. varmus and
http://web.mit.edu/newsoffice/tt/1996/oct02/42813.html
Published by the MIT News Office at the Massachusetts Institute of Technology, Cambridge, Mass. October 2 Tech Talk Search MIT News ... MIT
Varmus, Tsongas speak at Whitehead dedication
October 2 Tech Talk Search MIT News ... MIT

66. BioZoom: PubMed Og E-Biosci
Det skabte debat og skarpe reaktioner, da harold varmus for 5 mdr. online, elektroniskarkiv for biomedicinske forskningsresultater, kaldet E-biomed.
http://www.biokemi.org/biozoom/1999_4/bz_0499a.htm

Aktuelt
Arkiv Information BioZoom nr. 4 1999
PubMed og E-biosci - fagre nye verden
De oprindelige principper for forslaget om E-biomed består, men udvalgte dele er revideret og videreudviklet. For det første er navnet er ændret til PubMed Central, baseret på den naturlige sammenhæng med den eksisterende PubMed database for biomedicinsk litteratur i National Center for Biotechnology Information (NCBI). For det andet, er indholdet af databasen udvidet til at omfatte naturvidenskaber i almindelighed ved at medtage plante- og landbrugsforskning foruden biologi og medicin. For det tredje, vil screeningen af artikler uden "peer review" blive en opgave for grupper, som ikke har direkte forbindelse med NIH. PubMed central vil tillade indsendelse af manuskripter fra enhver organisation med mindst 3 medlemmer, som er ledende forskere med forskningsstøtte fra store offentlige og private fonde. Læserbreve i Science (4) og kommentarer på NIH’s web site (1) har kritiseret forslaget ved at fremhæve, at det nuværende system for udbredning af forskningsresultater er bemærkelsesværdigt effektivt og sikrer en høj kvalitet. Visse "high-impact" tidsskrifter fanger de mest dramatiske og interessante nye resultater, som læses af alle forskere. Andre disciplin-baserede tidsskrifter med varierende impact bringer veldokumenterede og betydningsfulde data, som kun læses af udvalgte eksperter. Det udbredte "peer review" af videnskabelige artikler er sacrosanct og sikrer værdien af de offentliggjorte resultater.

67. The Lasker Foundation | Former Award Winners, Basic Medical Research 1982
harold E. varmus, MD For his creative and successful pursuit towardthe identification of the cellular oncogenes and their control.
http://www.laskerfoundation.org/awards/library/1982basic.shtml
Lasker Awards Jury Members This Year's Winners Former Winners Library of Laureates
Browse the Library for former winners of the Albert Lasker Basic Medical Research Award select Clinical Research Award select Public Service Award select Special Achievement Award select Nominations
Open call to...
Nominate a Scientist

Former Winners, 1982
Albert Lasker Award for Basic Medical Research
J. Michael Bishop, M.D.
For his elegant elucidation of the nature of oncogenes, and his contribution to the discovery that these genes are present in normal cells.
Award Citation
For his fundamental and far-reaching discoveries concerning the nature of oncogenes and their profound importance and for determining that closely related genes occur not only throughout the animal kingdom, but also within the genome of cancer-causing retroviruses in humans.
In a long and particularly close scientific collaboration with Dr. Varmus, Dr. Bishop showed beyond question that a DNA sequence in the avian sarcoma virus was virtually identical to a sequence in normal human DNA. Moreover, they show that this sequence occurred in the genome of all vertebrates with only subtle alterations reflecting the gene's great age and the still mysterious, but vital identical role it must play. Dr. Bishop extended his studies by showing that this was only the first of a number of distinct oncogenes expressed at inappropriate levels in neoplastic tissues. He also showed how retroviruses such as the avian sarcoma virus reproduce and integrate with the genetic material of the infected cell.

68. Support Content For: E-Biomed Idea
1999 Dr. harold E. varmus National Institutes of Health One CenterDrive Bldg. 1, Room 126 Bethesda, MD 208920148. Dear Dr. varmus
http://www.asbmb.org/ASBMB/site.nsf/0/7A29F2F92008EA7585256C7C00535A7B?OpenDocum

69. Ex-NIH Director Now Favors Limiting Drug-Company Ties
consulting payments from drug companies, and require public disclosure of any paymentsmade to such officials, former NIH Director harold E. varmus said on
http://www.islet.org/forum/messages/31865.htm
Ex-NIH Director Now Favors Limiting Drug-Company Ties
Follow Ups Post Followup The Islet Foundation Message Forum FAQ Posted by Ellen on 16:45:34 2004/03/14 March 13, 2004 E-mail story Print
THE NATION
Ex-NIH Director Now Favors Limiting Drug-Company Ties
Harold Varmus lifted conflict-of-interest rules at National Institutes of Health. Many agency officials have consulting deals with the industry.
By David Willman, Times Staff Writer
BETHESDA, Md. The National Institutes of Health should prohibit its top officials from accepting many consulting payments from drug companies, and require public disclosure of any payments made to such officials, former NIH Director Harold E. Varmus said on Friday.
The NIH Blue Ribbon Panel on Conflict of Interest Policies is aiming to make recommendations to the current NIH director, Dr. Elias A. Zerhouni, by early May.
Zerhouni named the panel in response to a Dec. 7 report in the Los Angeles Times bringing to light hundreds of payments of consulting fees and stock options from biomedical companies to NIH employees, including two institute directors.
Varmus lifted the restrictions in 1995 to bring NIH policies more in line with less-stringent policies throughout the executive branch of government. At the time, Varmus did not respond to an invitation from the Office of Government Ethics to adopt more rigorous rules that would apply specifically to the NIH.

70. PAZ AHORA Peace Now. Nor NATO, Neither Taleban. No A La OTAN, No A Los Taliban.
Translate this page E) , Robert M. Solow(E) 3 , *Jack Steinberger (Ph) , Joseph H.Taylor, Jr.(Ph) , *CharlesH. Townes 2 (Ph) , Daniel C. Tsui (Ph) , harold E. varmus (M) , Robert
http://www.pazahora.org/noticia.asp?id=56

71. The Scientist :: Varmus Wants Tighter NIH Rules
wake of heightened concern over possible conflicts of interest at the National Institutesof Health (NIH), former NIH Director harold E. varmus now believes
http://www.biomedcentral.com/news/20040315/04/
Previous Next
Varmus wants tighter NIH rules
By Ted Agres
Varmus urged NIH's went into effect February 6 . That change, which was requested by NIH Director Elias A. Zerhouni in January, affects 66 senior officials including all NIH directors, deputy directors, scientific directors, and clinical directors. These officials now are required to file public disclosure forms, known as SF 278s, rather than the confidential OGE 450s. Varmus' views stand in contrast to positions he advocated while NIH director from 1993 to 1999. During that time, Varmus spearheaded efforts to ease restrictions on staff scientists and directors, allowing them greater freedom to interact with pharmaceutical companies and to engage in outside consulting activities. Those actions were needed, he said Friday, to attract and retain qualified scientists to NIH's intramural research program. The Los Angeles Times reported in December 2003 that several high-level NIH scientists and officials have received a total of more than $2.5 million in consulting fees and stock options from drug companies over the past 10 years. Zerhouni has since suspended approval of all new consulting arrangements, restructured the agency's system for implementing ethics regulations , and appointed a task force to examine these consulting deals, which have also become the topic of a Senate hearing. The blue ribbon panel is to report its recommendations by early May.

72. - EL MUNDO | Suplemento De Salud 345 - CIBERMED «E-Biomed»: Un Sistema Para Me
Translate this page harold varmus, director de los Institutos Nacionales de la Salud estadounidenses,una empresa de 1.716.000.000.000 pesetas, ha presentado el proyecto «E-Biomed
http://www.el-mundo.es/salud/1999/345/02678.html
Un suplemento de EL MUNDO Un servicio de DIRECTORIO Portada OTROS SUPLEMENTOS Magazine El Cultural Su Vivienda Motor ... Campus OTROS MUNDOS elmundo.es elmundo dinero elmundo ... elmundo CIBERMED «E-Biomed»: un sistema para mejorar la divulgación electrónica de la ciencia
Harold Varmus, director de los Institutos Nacionales de la Salud
estadounidenses, una empresa de 1.716.000.000.000 pesetas, ha presentado el
proyecto «E-Biomed», un sistema con el que se pretende estimular el debate
sobre la publicación electrónica y mejorar la divulgación.
Myriam López Blanco
Harold Varmus, premio Nobel y director de los Institutos Nacionales de la Salud
(NIH, de sus siglas en inglés) de Estados Unidos, va cada día en bicicleta
desde su casa, en el centro de Washington DC, hasta su oficina en Bethesda. Son
20 kilómetros de ida y, si todavía queda luz, 20 más de vuelta. Desde que
Clinton le nombró líder de los NIH, en 1993, este neoyorquino de 59 años no ha dejado de insuflar energía a esta institución. Cuando llegó, el Gobierno estaba amenazando con cortar el presupuesto anual para esta agencia. Hoy, Varmus está

73. - EL MUNDO | Suplemento De Salud 436 - Harold Varmus Aún Se Muestra Cauteloso A
Translate this page dirigido contra una diana molecular específica del cáncer— harold varmus se muestra desdedonde dirige el mejor centro de tratamiento e investigación del
http://www.el-mundo.es/salud/2001/436/991390140.html
Un suplemento de EL MUNDO Un servicio de DIRECTORIO Portada OTROS SUPLEMENTOS Magazine El Cultural Su Vivienda Motor ... Campus OTROS MUNDOS elmundo.es elmundo dinero elmundo ... elmundo ONCOLOGIA Harold Varmus aún se muestra cauteloso ante los nuevos hallazgos frente al cáncer
El científico en su despacho de la York Avenue de Nueva York. / MSKCC
Aún no quiere echar las campanas al vuelo. A pesar de que Gleevec (el STI571, el fármaco que controla la leucemia mieloide crónica mejor que cualquier otro) ha estado en la portada de los medios de comunicación de medio mundo —sobre todo por ser el primer producto dirigido contra una diana molecular específica del cáncer— Harold Varmus se muestra cauteloso.
«Todavía no sabemos si el producto prolonga la vida, si se generarán resistencias severas con el tiempo, si funciona en otros tipos de tumores además de en el sarcoma gastrointestinal, y si en el futuro las drogas que actúen de forma similar van a ser efectivas», afirma el científico en el despacho desde donde dirige el mejor centro de tratamiento e investigación del cáncer del mundo: el Memorial Sloan Kettering Cancer Center de Nueva York.

74. Biography.html
Dr. He later joined Dr. harold E. varmus’ laboratory at NIH in 1994, and therehe carried out research on Wnt signal transduction in Xenopus embryonic
http://www.helab.org/biography.html
Dr. Xi He’s Biography Dr. Xi He obtained his bachelor’s degree in 1982 in Mechanical Engineering at Huazhong University of Science and Technology in Wuhan, China. As a result of his increasing interest in biomedical research, he obtained a Master’s degree in Bioengineering at the same university and then entered the Ph.D program in biology at the University of California, San Diego (UCSD) in 1986. Dr. He performed his thesis research in Dr. Michael G. Rosenfeld’s laboratory, studying transcriptional regulation in mammalian brain development. After obtaining his Ph.D. in 1992, Dr. He moved to National Institutes of Health (NIH) as a postdoctoral fellow in Dr. Luis F. Parada’s group, studying the molecular genetics of neural development in mice. Dr. He later joined Dr. Harold E. Varmus’ laboratory at NIH in 1994, and there he carried out research on Wnt signal transduction in Xenopus embryonic development in collaboration with Dr. Igor Dawid’s group. Dr. He joined the Division of Neuroscience at Children’s Hospital and Harvard Medical School as an Assistant Professor in 1997. He is currently a faculty member of the Ph.D program in Biological and Biomedical Sciences at Harvard University, and a Guest Professor at the School of Life Science and Engineering, Tsinghua University in Beijing, China. Dr. He’s laboratory focuses on the molecular studies of signal transduction in vertebrate embryogenesis, and is supported by grants from NIH. Dr. He is a recipient of the Department of Defense Career Development Award and Johnson and Johnson Focused Giving Award, and is a Pew Scholar in Biomedical Sciences, Klingenstein Fellow in Neuroscience, and Keck Foundation Distinguished Young Scholar in Medical Research.

75. Premios Nobel De Medicina
retrovirales , Bishop, J. Michael; varmus, harold E. 1990, por
http://fai.unne.edu.ar/biologia/basicos/nobeles/nobelmed.htm
Premios Nobel de Medicina
Tema Ganador Behring, Emil Adolf Von Ross, Sir Ronald Finsen, Niels Ryberg Pavlov, Ivan Petrovich Koch, Robert Cajal, Santiago Ramon Y.; Golgi, Camillo Laveran, Charles Louis Alphonse Ehrlich, Paul; Metchnikoff, Ilya Ilyich Kocher, Emil Theodor Kossel, Albrecht Gullstrand, Allvar Carrel, Alexis Richet, Charles Robert Barany, Robert Bordet, Jules Krogh, Schack August Steenberger Hill, Sir Archibald Vivian; Meyerhof, Otto Fritz; Banting, Sir Frederick Grant; Macleod, John James Richard; Einthoven, Willem; Fibiger, Johannes Andreas Grib Wagner-Jauregg, Julius Nicolle, Charles Jules Henri Eijkman, Christiaan; Hopkins, Sir Frederick Gowland Landsteiner, Karl Warburg, Otto Heinrich Adrian, Lord Edgar Douglas; Sherrington, Sir Charles Scott Morgan, Thomas Hunt Minot, George Richards; Murphy, William Parry; Whipple, George Hoyt Spemann, Hans Dale, Sir Henry Hallett; Loewi, Otto Nagyrapolt, Albert Szent-Gyorgyi Von Heymans, Corneille Jean Francois Domagk, Gerhard Dam, Henrik Carl Peter; Doisy, Edward Adelbert Erlanger, Joseph; Gasser, Herbert Spencer

76. Harold E. Meyer - Isbn 013011488X Lifetime Encyclopedia Of Letters 0735202184 01
Bookshelf) harold E Richardson. harold E varmus John M Coffin Retrovirusesharold E varmus John M Coffin. harold Ed. Bloom Lionel Trilling
http://www.cheapusedbooks.net/36729_haroldemeyer.html

Harold E. Meyer
book Lifetime Encyclopedia of Letters Lifetime Encyclopedia of Letters with CDROM / book Writer Harold E. Meyer
Harold E. Meyer Scott A. Sievert Credit Collection Letters That Get Results
Credit Collection Letters That Get Results
Harold E Richardson Cassius Marcellus Clay : Firebrand of Freedom (Kentucky Bicentennial Bookshelf)
Harold E Richardson Harold E Varmus John M Coffin Retroviruses Harold E Varmus John M Coffin Harold Ed. Bloom Lionel Trilling Harold Bloom The Victorian Prose and Poetry Harold Ed. Bloom Lionel Trilling Harold Bloom Harold Edward Stassen Marshall Houts Eisenhower: Turning the World toward Peace Eisenhower: Turning the World toward Peace Harold Edward Stassen Marshall Houts Harold Ellis The Spleen Clio Chirurgica No 9 The Spleen Clio Chirurgica No 9 Harold Epstein Gardening in the Shade Plants and Gardens Vol 25 No 3 Harold Epstein Harold Eugene Davis Henry Gradys New South : Atlanta, a Brave and Beautiful City Henry Gradys New South : Atlanta, a Brave and Beautiful City books index
Book Index
Book links
  • Handbook of Religion and Mental Health - Harold George Koenig The American Century, 1945-1965: Battling Communism Without, Segregation Within - Harold Evans Ira Claffey
  • 77. American Society For Investigative Pathology
    harold E. varmus, MD, Director National Institutes of Health 9000 RockvillePike Building 1, Room 126 Bethesda, MD 20892 Dear Dr. varmus
    http://www.asip.org/paffairs/varmus.htm

    The American Society for Investigative Pathology
    Public Affairs 1999 ASIP Response to NIH E-Biomed Proposal

    May 13, 1999 Harold E. Varmus, M.D., Director
    National Institutes of Health
    9000 Rockville Pike
    Building 1, Room 126
    Bethesda, MD 20892
    Dear Dr. Varmus: The American Society for Investigative Pathology is pleased to respond to your E-Biomed proposal. The Society is excited by the prospect of a centralized biomedical pre-print server, but is quite concerned about the feasibility of the peer-reviewed component of E- Biomed. Representing the membership, the councilors of the Society were asked to comment on the proposal and I have summarized below our collective views. Pre-Print Server: The Society fully supports the notion of a pre-print server ("E-Biomed general repository") as a tool for improving the speed and circulation of advances in research. It is suggested that care be taken to consider the possible ramifications of universal access, especially as it concerns clinical material and the "lay" community. The potential liability of misuse of information could well occur and must be guarded against. Single Search Engine: Archival Function: The Society strongly endorses the NIH's efforts to create a central archive for complex data sets and other progressive modes of storing information, such as videos. The NIH has demonstrated success in this area with GenBank and is a logical choice for archiving other materials responsibly and effectively.

    78. NIH Proceeds With On-Line Archive Of Research Papers
    then called Ebiomed, we have heard from hundreds of people and have had discussionswith dozens of interested organizations, harold E. varmus, the director
    http://www.beachbrowser.com/Archives/Science-and-Health/September-99/Varmus-Says
    "Improving the Quality of Information in Northwest Florida..." Main Menu Contact Local News National News Science and Health Entertainment News Environmental News Opinions Freedom Forum I Freedom Forum II Gaylans Corner Cool Stuff! Information Archives
    Be one of the thousands that have helped BeachBrowser keep on delivering the news.
    !!DONATE HERE!! Varmus Says NIH Will Proceed With On-Line Archive of Research Papers By VINCENT KIERNAN The National Institutes of Health announced that it would proceed with a controversial on-line archive of scholarly papers in the life sciences that will be freely available to all. The archive has attracted the ardent opposition of some scholarly societies and for-profit journal publishers. The archive, previously called E-biomed, now will be named PubMed Some scholarly societies and commercial journal publishers have objected that the archive would discourage subscriptions to their journals.

    79. ARL Bimonthly Report 205: NIH Proposes E-biosci
    1. harold varmus, EBIOMED A Proposal for Electronic Publications in the BiomedicalSciences, 5 May 1999 (Draft), 20 June 1999 (Addendum), http//www.nih
    http://www.arl.org/newsltr/205/ebiosci.html
    NIH Proposes E-biosci
    by Mary M. Case, Director, Office of Scholarly Communication Originally named E-biomed, the project is now called E-biosci and has expanded beyond biomedical literature to include all of the life sciences. In the document outlining the proposal, Varmus states: "In this essay, we propose a system for electronic publication of new results and ideas in the biomedical sciences. We do this with the conviction that such means of publication can accelerate the dissemination of information, enrich the reading experience, deepen discussions among scientists, reduce frustrations with traditional mechanisms for publication, and save substantial sums of public and private money." E-biosci has come under fire from some publishers who believe that it would undermine the entire economic incentive for publishing. Varmus acknowledges that subscriptions may decline, but encourages societies to explore alternatives for raising revenue. He suggests that the review process could be sustained by page charges or submission fees paid by authors. In a recent meeting with the ARL Board of Directors, Dr. David Lipman, Director of the National Center for Biotechnology Information (NCBI) at the National Library of Medicine and a colleague of Dr. Varmus, indicated that E-biosci is moving forward despite the opposition from publishers. Lipman noted that several societies who had spoken out against E-biosci were now working with them. These ongoing discussions have resulted in the evolution of the E-biosci concept. Lipman also reported that Congress has requested start date and budget information from NIH.

    80. Frankenstein Exhibit Home Page
    cloned human beings. In testimony before Congress, National Institutesof Health director harold E. varmus took a similar stance.
    http://www.ulib.iupui.edu/frankenstein/promise.html
    Films School of Liberal Arts BookMarks Medical Historical Society ... Calendar of Events
    Promise and Peril
    "They may come up with a disease that can't be cured, even a monster. Is this the answer to Dr. Frankenstein's dream?" The time was the early 1970s. The speaker was the mayor of Cambridge, Massachusetts, warning against a proposed DNA laboratory at Harvard University. Today, we almost expect to hear references to "Frankenstein"whether monster, scientist, novel, film, image, or myth is often unclearwhenever some powerful new technology poses risk to humankind or challenges our ideas of what it means to be human. The atomic bomb, interspecies organ transplants, genetic engineering, and cloning, among many others, have each prompted such warnings; Mary Shelley's hideous brainchild continues to embody and express our fears.
    The Search for Balance
    What is "acceptable" science and medicine? Who decides? How can society balance the benefits of new medical discoveries against ethical or spiritual questions they may pose? Or the human urge to know and understand against problems arising from that knowledge?

    A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

    Page 4     61-80 of 97    Back | 1  | 2  | 3  | 4  | 5  | Next 20

    free hit counter